185 related articles for article (PubMed ID: 24972322)
1. Metrological traceability in mass spectrometry-based targeted protein quantitation: a proof-of-principle study for serum apolipoproteins A-I and B100.
Smit NP; Romijn FP; van den Broek I; Drijfhout JW; Haex M; van der Laarse A; van der Burgt YE; Cobbaert CM
J Proteomics; 2014 Sep; 109():143-61. PubMed ID: 24972322
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interspecimen trypsin digestion efficiency prior to multiple reaction monitoring-based absolute protein quantification with native protein calibrators.
van den Broek I; Smit NP; Romijn FP; van der Laarse A; Deelder AM; van der Burgt YE; Cobbaert CM
J Proteome Res; 2013 Dec; 12(12):5760-74. PubMed ID: 24168082
[TBL] [Abstract][Full Text] [Related]
3. Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping.
van den Broek I; Romijn FP; Nouta J; van der Laarse A; Drijfhout JW; Smit NP; van der Burgt YE; Cobbaert CM
Clin Chem; 2016 Jan; 62(1):188-97. PubMed ID: 26585923
[TBL] [Abstract][Full Text] [Related]
4. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum.
Kay RG; Gregory B; Grace PB; Pleasance S
Rapid Commun Mass Spectrom; 2007; 21(16):2585-93. PubMed ID: 17639571
[TBL] [Abstract][Full Text] [Related]
5. Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow.
van den Broek I; Nouta J; Razavi M; Yip R; Bladergroen MR; Romijn FP; Smit NP; Drews O; Paape R; Suckau D; Deelder AM; van der Burgt YE; Pearson TW; Anderson NL; Cobbaert CM
Methods; 2015 Jun; 81():74-85. PubMed ID: 25766926
[TBL] [Abstract][Full Text] [Related]
6. Quantifying protein measurands by peptide measurements: where do errors arise?
van den Broek I; Romijn FP; Smit NP; van der Laarse A; Drijfhout JW; van der Burgt YE; Cobbaert CM
J Proteome Res; 2015 Feb; 14(2):928-42. PubMed ID: 25494833
[TBL] [Abstract][Full Text] [Related]
7. Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests.
Ruhaak LR; Romijn FPHTM; Begcevic Brkovic I; Kuklenyik Z; Dittrich J; Ceglarek U; Hoofnagle AN; Althaus H; Angles-Cano E; Coassin S; Delatour V; Deprez L; Dikaios I; Kostner GM; Kronenberg F; Lyle A; Prinzing U; Vesper HW; Cobbaert CM
Clin Chem; 2023 Mar; 69(3):251-261. PubMed ID: 36644914
[TBL] [Abstract][Full Text] [Related]
8. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Deshaies Y; Gagné C; Couture P
Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
[TBL] [Abstract][Full Text] [Related]
9. A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry.
Lassman ME; McLaughlin TM; Somers EP; Stefanni AC; Chen Z; Murphy BA; Bierilo KK; Flattery AM; Wong KK; Castro-Perez JM; Hubbard BK; Roddy TP
Rapid Commun Mass Spectrom; 2012 Jan; 26(2):101-8. PubMed ID: 22173797
[TBL] [Abstract][Full Text] [Related]
10. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures.
Hoofnagle AN; Becker JO; Oda MN; Cavigiolio G; Mayer P; Vaisar T
Clin Chem; 2012 Apr; 58(4):777-81. PubMed ID: 22307200
[TBL] [Abstract][Full Text] [Related]
11. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
12. Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration.
Cobbaert CM; Althaus H; Begcevic Brkovic I; Ceglarek U; Coassin S; Delatour V; Deprez L; Dikaios I; Dittrich J; Hoofnagle AN; Kostner GM; Kronenberg F; Kuklenyik Z; Prinzing U; Vesper HW; Zegers I; Ruhaak LR;
Clin Chem; 2021 Mar; 67(3):478-489. PubMed ID: 33331636
[TBL] [Abstract][Full Text] [Related]
13. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
[TBL] [Abstract][Full Text] [Related]
14. A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.
Blanchard V; Garçon D; Jaunet C; Chemello K; Billon-Crossouard S; Aguesse A; Garfa A; Famchon G; Torres A; Le May C; Pichelin M; Bigot-Corbel E; Lambert G; Cariou B; Hadjadj S; Krempf M; Bach-Ngohou K; Croyal M
J Lipid Res; 2020 Jul; 61(7):1128-1139. PubMed ID: 32404332
[TBL] [Abstract][Full Text] [Related]
15. Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example.
Kumar A; Gangadharan B; Cobbold J; Thursz M; Zitzmann N
Sci Rep; 2017 Sep; 7(1):12072. PubMed ID: 28935895
[TBL] [Abstract][Full Text] [Related]
16. Low rate of production of apolipoproteins B100 and AI in 2 patients with Anderson disease (chylomicron retention disease).
Ouguerram K; Zaïr Y; Kasbi-Chadli F; Nazih H; Bligny D; Schmitz J; Aparicio T; Chétiveaux M; Magot T; Aggerbeck LP; Samson-Bouma ME; Krempf M
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1520-5. PubMed ID: 22441101
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation.
Percy AJ; Simon R; Chambers AG; Borchers CH
J Proteomics; 2014 Jun; 106():113-24. PubMed ID: 24769237
[TBL] [Abstract][Full Text] [Related]
18. An MRM-Based Multiplexed Quantification Assay for Human Adipokines and Apolipoproteins.
Krieg L; Schaffert A; Kern M; Landgraf K; Wabitsch M; Beck-Sickinger AG; Koerner A; Blüher M; von Bergen M; Schubert K
Molecules; 2020 Feb; 25(4):. PubMed ID: 32054032
[TBL] [Abstract][Full Text] [Related]
19. Targeted proteomics using stable isotope labeled protein fragments enables precise and robust determination of total apolipoprotein(a) in human plasma.
Hober A; Rekanovic M; Forsström B; Hansson S; Kotol D; Percy AJ; Uhlén M; Oscarsson J; Edfors F; Miliotis T
PLoS One; 2023; 18(2):e0281772. PubMed ID: 36791076
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma: Workflow for Large-Scale Analysis of Biobank Samples.
Rezeli M; Sjödin K; Lindberg H; Gidlöf O; Lindahl B; Jernberg T; Spaak J; Erlinge D; Marko-Varga G
J Proteome Res; 2017 Sep; 16(9):3242-3254. PubMed ID: 28738677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
